OGEN vs TT · rev $37.7K vs P/E 36, rev $21.32B
Oragenics Inc (OGEN) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
OGEN currently screens at market cap $2.7M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the OGEN and TT stock pages for the full models.
Not investment advice.